Source: International Congress 2017 – PAH and CTEPH
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Harutyunova (Heidelberg, Germany). Incidence of new pulmonary hypertension and determining factors during follow-up of patients with systemic sclerosis after negative right heart catheterisation. 2416

Member's Comments

No comment yet.

Related content which might interest you: Incidence of pulmonary hypertension and determining factors in patients with systemic sclerosis Source: Eur Respir J, 51 (4) 1701197; 10.1183/13993003.01197-2017 Year: 2018 Risk factors associated with pulmonary arterial hypertension in patients with systemic sclerosis and implications for screening Source: Eur Respir Rev 2011; 20: 270-276 Year: 2011 Risk assessment in patients with systemic sclerosis and pulmonary arterial hypertension Source: Eur Respir J, 52 (4) 1801745; 10.1183/13993003.01745-2018 Year: 2018 Predictors of pulmonary artery hypertension in patients with systemic sclerosis Source: Annual Congress 2012 - Respiratory manifestations of systemic disease: a holistic approach Year: 2012 Does left heart disease cause most systemic sclerosis associated pulmonary hypertension? Source: Eur Respir J 2013; 42: 888-890 Year: 2013 Identifying early pulmonary arterial hypertension in patients with systemic sclerosis Source: Eur Respir J, 51 (4) 1800495; 10.1183/13993003.00495-2018 Year: 2018 Prognostic factors in pulmonary arterial hypertension: assessing the course of the disease Source: Eur Respir Rev 2011; 20: 236-242 Year: 2011 Hemodynamic phenotypes in systemic sclerosis patients screened for pulmonary hypertension – impact of the new PH-definition Source: International Congress 2019 – Pulmonary arterial hypertension: recent advances from the bedside Year: 2019 Haemodynamics and serial risk assessment in systemic sclerosis associated pulmonary arterial hypertension Source: Eur Respir J, 52 (4) 1800678; 10.1183/13993003.00678-2018 Year: 2018 Survival and prognostic factors in patients with incident systemic sclerosis-associated pulmonary arterial hypertension from the French registry Source: Annual Congress 2011 - Clinical features of pulmonary hypertension Year: 2011 A screening protocol for pulmonary hypertension in systemic sclerosis identifies patients with pulmonary hypertension on exercise Source: Eur Respir J 2004; 24: Suppl. 48, 277s Year: 2004 Clinical phenotypes and outcomes of pulmonary hypertension due to left heart disease: role of the pre-capillary component Source: International Congress 2017 – Outcomes and new treatment strategies in pulmonary hypertension Year: 2017 Isolated right ventricular dysfunction in systemic sclerosis: latent pulmonary hypertension? Source: Eur Respir J 2007; 30: 928-936 Year: 2007 Hospitalization in patients with pulmonary arterial hypertension: causes and outcomes Source: Annual Congress 2009 - Pulmonary circulation I Year: 2009 Impact of two 5-year anticoagulant strategies on survival and echocardiographic parameters in the patients with chronic thromboembolic pulmonary hypertension (CTEPH) who did not undergo pulmonary endarterectomy Source: Annual Congress 2004 - Pulmonary embolism Year: 2004 Haemodynamics to predict outcome in pulmonary hypertension due to left heart disease: a meta-analysis Source: Eur Respir J, 51 (4) 1702427; 10.1183/13993003.02427-2017 Year: 2018 Ventricular mass index correlates with pulmonary haemodynamics in patients with systemic sclerosis and suspected pulmonary arterial hypertension Source: Annual Congress 2008 - Pulmonary hypertension I Year: 2008 Comparison of clinical characteristics in patients with pulmonary arterial hypertension and inoperable chronic thromboembolic pulmonary hypertension Source: Annual Congress 2008 - Pulmonary venous thromboembolic disease Year: 2008 Is right heart catheterisation still a fundamental part of the follow-up assessment of pulmonary arterial hypertension? The argument against Source: Eur Respir J, 52 (1) 1800996; 10.1183/13993003.00996-2018 Year: 2018 Age, risk and outcomes in idiopathic pulmonary arterial hypertension Source: Eur Respir J, 51 (5) 1800629; 10.1183/13993003.00629-2018 Year: 2018